Applying Expert Knowledge for ICH M7 Impurity Classification - Session 1

  Рет қаралды 8,029

MultiCASE, Inc

MultiCASE, Inc

Күн бұрын

Пікірлер: 4
@yomudon2
@yomudon2 4 жыл бұрын
46:36 "API or related compounds to the API" may be better, because Ames test data of some related compounds to the API (e.g. process intermediate) are usually collected for manufacturing.
@yomudon2
@yomudon2 4 жыл бұрын
It's fun. I enjoyed it. Was 2-amino-1,3,4-thiazoles recognized as deactivating/ mitigating feature in GT_BMUT? I'm interested in how to review compounds with deactivating/ mitigating features. I'm looking forward to the part 2!!
@MultiCASEinc
@MultiCASEinc 4 жыл бұрын
Glad you enjoyed! Yes, the GT1_BMUT picks up 4 analogs which is not enough to produce an alert however GT_EXPERT picks up the alert. Part 2 next week...July 7th!
@yomudon2
@yomudon2 4 жыл бұрын
@@MultiCASEinc However statistical-based is likely to be positive prediction in case study4.
Applying Expert Knowledge for ICH M7 Classification - Session 2
1:37:54
MultiCASE, Inc
Рет қаралды 1,3 М.
The purge factor - ICH M7 Option 4
11:20
Fernanda Waechter
Рет қаралды 24 М.
Каха и дочка
00:28
К-Media
Рет қаралды 3,4 МЛН
Don’t Choose The Wrong Box 😱
00:41
Topper Guild
Рет қаралды 62 МЛН
coco在求救? #小丑 #天使 #shorts
00:29
好人小丑
Рет қаралды 120 МЛН
Introduction to Cyclic Voltammetry
13:35
Pine Research Instrumentation, Inc.
Рет қаралды 140 М.
Graphene, a 2D Nanomaterials
47:43
NPTEL-NOC IITM
Рет қаралды 10 М.
Understanding ICH Q8, 9 and 10
15:29
Inspired Pharma Training
Рет қаралды 15 М.
Fatty Acid (Beta) Oxidation
25:06
Dirty Medicine
Рет қаралды 417 М.
Think Fast, Talk Smart: Communication Techniques
58:20
Stanford Graduate School of Business
Рет қаралды 43 МЛН
Regulatory Considerations for Impurity Qualification: ICH Q3A/Q3C/Q3D, RLD & MDD
28:12
U.S. Food and Drug Administration
Рет қаралды 10 М.
Каха и дочка
00:28
К-Media
Рет қаралды 3,4 МЛН